(Q35587926)

9 August 2017

1 reference

title

Dosing of medications in morbidly obese patients in the intensive care unit setting (English)

1 reference

9 August 2017

0 references

1 reference

Brian L Erstad

1

1 reference

9 August 2017

language of work or name

1 reference

19 November 2003

1 reference

9 August 2017

published in

Intensive Care Medicine

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

18-32

1 reference

Lidocaine disposition in obesity.

9 August 2017

cites work

1 reference

12 December 2020

Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects.

1 reference

12 December 2020

Body weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgery

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient

1 reference

12 December 2020

Pharmacokinetics of ranitidine in morbidly obese women

1 reference

12 December 2020

Tissue plasminogen activator for acute ischemic stroke

1 reference

12 December 2020

Obesity and post-operative pain.

1 reference

12 December 2020

Phenytoin disposition in obesity. Determination of loading dose

1 reference

12 December 2020

The meaning and measurement of lean body mass

1 reference

12 December 2020

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

12 December 2020

A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction

1 reference

12 December 2020

Pharmacokinetics of theophylline in obesity

1 reference

12 December 2020

Prophylactic cefazolin in gastric bypass surgery.

1 reference

12 December 2020

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

1 reference

12 December 2020

Intravenous ciprofloxacin dosing in a morbidly obese patient

1 reference

12 December 2020

Effect of age, gender, and obesity on midazolam kinetics.

1 reference

12 December 2020

Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.

1 reference

12 December 2020

Tobramycin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Theophylline disposition in obesity

1 reference

12 December 2020

Alterations in drug distribution and clearance due to obesity

1 reference

12 December 2020

The effect of body weight on dalteparin pharmacokinetics. A preliminary study

1 reference

12 December 2020

Remifentanil pharmacokinetics in obese versus lean patients.

1 reference

12 December 2020

Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis

1 reference

12 December 2020

Antibiotic prophylaxis for surgery in morbidly obese patients

1 reference

12 December 2020

Cimetidine disposition in obesity

1 reference

12 December 2020

Pharmacokinetics of dopamine in healthy male subjects

1 reference

12 December 2020

Vancomycin pharmacokinetics in normal and morbidly obese subjects

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium

1 reference

12 December 2020

Bar code documentation of pharmacotherapy services in intensive care units

1 reference

12 December 2020

Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation

1 reference

12 December 2020

Digoxin disposition in obesity: Clinical pharmacokinetic investigation

1 reference

12 December 2020

Variation in postoperative analgesic requirements in the morbidly obese following gastric bypass surgery

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity

1 reference

12 December 2020

Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers

1 reference

12 December 2020

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

12 December 2020

Dosing and monitoring of low-molecular-weight heparins in special populations

1 reference

12 December 2020

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

1 reference

12 December 2020

Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers

1 reference

12 December 2020

Pyrogenic reactions associated with single daily dosing of intravenous gentamicin.

1 reference

12 December 2020

Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients

1 reference

12 December 2020

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

12 December 2020

Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors

1 reference

12 December 2020

Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units

1 reference

12 December 2020

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

12 December 2020

Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.

1 reference

12 December 2020

Pharmacokinetics of rocuronium bromide in obese female patients.

1 reference

12 December 2020

Effects of obesity on pharmacokinetics implications for drug therapy

1 reference

12 December 2020

Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism

1 reference

12 December 2020

Intravenous ciprofloxacin disposition in obesity

1 reference

12 December 2020

Calculation of heparin dosage in a morbidly obese woman

1 reference

12 December 2020

Vancomycin dosing in morbidly obese patients

1 reference

12 December 2020

Determination of ideal body weight for drug dosage calculations.

1 reference

12 December 2020

Aminoglycoside dosing weight correction factors for patients of various body sizes

1 reference

12 December 2020

Procainamide Disposition in Obesity

1 reference

12 December 2020

Verapamil pharmacodynamics and disposition in obese hypertensive patients

1 reference

12 December 2020

Pharmacokinetics of amiodarone: implications for drug therapy

1 reference

12 December 2020

Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patients

1 reference

12 December 2020

Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients

1 reference

12 December 2020

10.1007/S00134-003-2059-6

Identifiers

DOI

1 reference

release_rndqmmues5eepmydniischnhfm

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rndqmmues5eepmydniischnhfm

24 November 2022

mapped directly with Wikidata item

1 reference